Sentinel Lymph Node Biopsy in Melanoma: Overview and Updates

Area of Science:

• Oncology
• Surgical Oncology
• Dermatology

Background:

• Regional lymph nodes are critical in melanoma metastasis.
• Sentinel lymph node biopsy (SLNB) is a standard procedure for melanoma staging.
• Adjuvant therapies are transforming melanoma management.

Purpose of the Study:

• To review the evolving role of SLNB in melanoma management.
• To analyze recent findings on SLNB in the context of adjuvant therapies.
• To highlight consensus and controversies surrounding SLNB.

Main Methods:

• Systematic review of recent publications on SLNB in melanoma.
• Analysis of themes and findings related to adjuvant therapy integration.
• Evaluation of SLNB's current utility and future implications.

Main Results:

• SLNB continues to be a valuable tool for melanoma staging.
• SLNB may offer therapeutic benefits beyond staging.
• Ongoing controversies exist regarding optimal patient selection and indications.
• Adjuvant therapies impact the decision-making process for SLNB.

Conclusions:

• SLNB remains an important component of melanoma management.
• Optimal patient selection for SLNB requires balancing individual risk and adjuvant therapy benefits.
• Further research is needed to refine SLNB indications in the era of novel therapies.